MedTrace Logo

IntraCardiac Echocardiography sysTem

NCT06392243 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2024-04-30

No results posted yet for this study

Summary

To evaluate the safety and effectiveness of intracardiac ultrasound imaging system in Sonosemi Medical Co., Ltd.

Conditions

  • Heart Diseases

Interventions

DEVICE

Intracardiac ultrasound imaging system

The control group was treated with SOUNDSTAR 3D Diagnostic Ultrasound catheter (SNDSTR10G) and Vivid IQ, intracardiac and macrovascular imaging of the heart, assessment of intracardiac Doppler flow, and guidance for intracardiac intervention

Sponsors & Collaborators

  • Sonosemi Medical Co., Ltd.

    lead OTHER

Principal Investigators

  • He Ben · Shanghai Chest Hospital

  • Chu Huimin · Ningbo No. 1 Hospital

  • Li Haiying · The University of Hong Kong-Shenzhen Hospital

  • Ma Wei · Peking University First Hospital

  • Ning Zhongping · Zhoupu Hospital, Pudong New Area, Shanghai, China

  • Zhang Xiwen · Huai'an First People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-22
Primary Completion
2023-10-23
Completion
2023-12-23

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06392243 on ClinicalTrials.gov